Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Y Dodd

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Current Opinion in Hematology|September 28, 2007
Current risk for transfusion transmitted infectionsRoger Y Dodd
Future Microbiology|April 30, 2011
Chronic fatigue syndrome, XMRV and blood safetyRoger Y Dodd
Transfusion|September 8, 2011
B19: benign or not?Roger Y Dodd
The Journal of Infectious Diseases|October 20, 2005
Plasma collection and donor safety in rural ChinaRoger Y Dodd
Transfusion|January 19, 2017
Epidemiology, performance characteristics, or both?Roger Y Dodd
Clinical Chemistry|March 2, 2010
CommentaryRoger Y Dodd
Transfusion|March 7, 2019
Concerning the efficacy of pathogen inactivationRoger Y Dodd
Transfusion|July 13, 2013
Infectivity of occult hepatitis B from two different points of viewCelso Bianco, Roger Y Dodd
Transfusion|June 16, 2010
Human herpesvirus-8: what (not) to do redux?Louis M Katz, Roger Y Dodd
Annual Review of Medicine|January 30, 2004
Emerging infectious threats to the blood supplyRoger Y Dodd, David A Leiby
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Current Opinion in Hematology|September 28, 2007
Current risk for transfusion transmitted infectionsRoger Y Dodd
Future Microbiology|April 30, 2011
Chronic fatigue syndrome, XMRV and blood safetyRoger Y Dodd
Transfusion|September 8, 2011
B19: benign or not?Roger Y Dodd
The Journal of Infectious Diseases|October 20, 2005
Plasma collection and donor safety in rural ChinaRoger Y Dodd
Transfusion|January 19, 2017
Epidemiology, performance characteristics, or both?Roger Y Dodd
Clinical Chemistry|March 2, 2010
CommentaryRoger Y Dodd
Transfusion|March 7, 2019
Concerning the efficacy of pathogen inactivationRoger Y Dodd
Transfusion|July 13, 2013
Infectivity of occult hepatitis B from two different points of viewCelso Bianco, Roger Y Dodd
Transfusion|June 16, 2010
Human herpesvirus-8: what (not) to do redux?Louis M Katz, Roger Y Dodd
Annual Review of Medicine|January 30, 2004
Emerging infectious threats to the blood supplyRoger Y Dodd, David A Leiby
Pageof 13